Existing horizon scanning activities could be strengthened to aid budget planning in the context of high upfront cost therapies such as gene therapies. International collaborations could be leveraged ...
The Office of Health Economics is delighted to host the Health Economists’ Study Group Summer Meeting, which will run from 30th June – 2nd July 2025. Founded in 1972, the Health Economists’ Study ...
Last week, researchers from across the UK and Ireland met at Holborn’s Conway Hall for a day of stimulating presentations and ...
The policy environment for rare disease and orphan medicines is complex and encompasses regulation, reimbursement, and ...
Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions ...
Hannah joined OHE as an Economist in September 2024. She holds an MPharm degree from the University of Nottingham and an MSc in Health Economics and Health Policy from the University of Birmingham. As ...
Michael Drummond is Professor Emeritus and former Director of the Centre for Health Economics at the University of York in the United Kingdom. His main field of interest is in the economic evaluation ...
Chittawan Poonsiri is a Senior Associate at the Research International Unit (RIU) at HITAP. She earned her degree from the International Program at the Faculty of Pharmaceutical Sciences, Khon Kaen ...
Dr Seán Byrne is Senior Manager, Legal & Regulatory Affairs for the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Seán represents EUCOPE members at relevant European Medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback